Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant
Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant
Not yet recruiting · NCT06768697 · Registry updated 2025-01-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Not yet recruiting | Early phase 1 | 2025-01-10 | NCT06768697 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Public Health Clinical Center | 16 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Public Health Clinical Center,Fudan University | Shanghai | China | 1 |